Alnylam Pharmaceuticals Inc (ALNY) — Tangible Net Worth Ratio
Alnylam Pharmaceuticals Inc (ALNY) has a Tangible Net Worth Ratio of 24.8% as of December 2025. This metric is calculated by deducting intangible assets ($593.73 Million) from net assets ($789.18 Million) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. See Alnylam Pharmaceuticals Inc (ALNY) working capital ratio to evaluate short-term liquidity relative to the company's equity base.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
Alnylam Pharmaceuticals Inc Tangible Net Worth Ratio (2004–2025)
This chart shows how Alnylam Pharmaceuticals Inc's Tangible Net Worth Ratio has changed across 20 annual periods from 2004 to 2025. As of December 2025, the ratio stands at 24.8%, reflecting net assets of $789.18 Million with intangible assets of $593.73 Million USD. See Alnylam Pharmaceuticals Inc defensive liquidity buffer to measure how many days the company can operate on defensive assets alone.
Annual Tangible Net Worth Ratio for Alnylam Pharmaceuticals Inc (2004–2025)
The table below presents the year-by-year Tangible Net Worth Ratio for Alnylam Pharmaceuticals Inc from 2004 to 2025, covering 20 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. For the full company profile including market capitalisation, see Alnylam Pharmaceuticals Inc market cap and net worth.
| Year | Tangible NW Ratio | Net Assets (USD) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 24.8% | $789.18 Million | $593.73 Million | $4.97 Billion | ▼ -75.2 pp |
| 2024 | 100.0% | $67.09 Million | $0.00 | $4.24 Billion | ▲ +0.0 pp |
| 2021 | 100.0% | $588.20 Million | $0.00 | $3.64 Billion | ▲ +0.0 pp |
| 2020 | 100.0% | $1.02 Billion | $0.00 | $3.41 Billion | ▲ +0.0 pp |
| 2019 | 100.0% | $1.44 Billion | $0.00 | $2.40 Billion | ▲ +0.0 pp |
| 2018 | 100.0% | $1.30 Billion | $0.00 | $1.57 Billion | ▲ +0.0 pp |
| 2017 | 100.0% | $1.77 Billion | $0.00 | $1.99 Billion | ▲ +0.0 pp |
| 2016 | 100.0% | $920.22 Million | $0.00 | $1.26 Billion | ▲ +0.0 pp |
| 2015 | 100.0% | $1.26 Billion | $0.00 | $1.39 Billion | ▲ +0.0 pp |
| 2014 | 100.0% | $936.27 Million | $0.00 | $1.08 Billion | ▲ +0.0 pp |
| 2013 | 100.0% | $270.35 Million | $0.00 | $420.53 Million | ▲ +0.0 pp |
| 2012 | 100.0% | $134.05 Million | $0.00 | $287.52 Million | ▲ +0.2 pp |
| 2011 | 99.8% | $118.00 Million | $275.00K | $281.92 Million | ▲ +0.1 pp |
| 2010 | 99.7% | $158.23 Million | $448.00K | $393.26 Million | ▲ +0.1 pp |
| 2009 | 99.7% | $177.97 Million | $622.00K | $481.38 Million | ▲ +0.0 pp |
| 2008 | 99.6% | $202.12 Million | $795.00K | $554.68 Million | ▲ +0.1 pp |
| 2007 | 99.5% | $199.17 Million | $968.00K | $493.79 Million | ▲ +0.5 pp |
| 2006 | 99.0% | $201.17 Million | $1.93 Million | $240.01 Million | ▲ +3.1 pp |
| 2005 | 96.0% | $61.78 Million | $2.49 Million | $98.35 Million | ▲ +3.3 pp |
| 2004 | 92.6% | $46.14 Million | $3.40 Million | $66.11 Million | — |